Overview
- The paper, published in the journal Allergy on Oct. 29 and summarized in a Nov. 20 press release, presents an 'outside‑in' bioenergetic hypothesis that many allergic diseases may start with mitochondrial dysfunction in epithelial barrier cells.
- The strongest and most consistent signal was in eosinophilic oesophagitis, where genes that clear damaged mitochondria were reduced across 13 independent patient cohorts.
- The mitochondrial or barrier‑cell signal was uneven across conditions: it was only partly present in hay fever and was not detected in established asthma or nasal polyps.
- The claim is based on a large multi‑omic reanalysis covering 116 case‑control cohorts and about 3,776 patients with co‑authors from institutions in Australia, the US, Europe and Asia.
- Authors stress this is a testable hypothesis that needs prospective studies—for example sampling infants’ barrier cells before disease onset—and say validation could reorient prevention and therapies upstream of the immune response.